Sign in
4

Changes in Ownership

Mineralys Therapeutics, Inc. Filed Acc 0001933414-24-000042

Chief Medical Officer acquired 11,367 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Rodman David Malcom Chief Medical Officer 2024-09-11 Option exercise +5,018 $0.54 $2,710 119,256 D
Rodman David Malcom Chief Medical Officer 2024-09-12 Option exercise +6,349 $1.08 $6,857 125,605 D
Derivatives
Rodman David Malcom Chief Medical Officer 2024-09-11 Option exercise · Stock Option −5,018 20,069 D
Rodman David Malcom Chief Medical Officer 2024-09-12 Option exercise · Stock Option −6,349 170,786 D
Loading xslF345X05/wk-form4_1726173125.xml…